<DOC>
	<DOCNO>NCT02094898</DOCNO>
	<brief_summary>Study hypothesis : Do serial low-dose ketamine infusion , follow weekly maintenance infusion , increase length time depressive symptom stay remission length time associate suicide risk improve ? Brief Summary : This open label clinical trial intend clarify initial response low-dose ketamine infusion repeat dose maintenance treatment model . Primary outcome reduction depression severity reduction suicide risk along duration response .</brief_summary>
	<brief_title>Ketamine Depression Suicide Risk</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Suicide</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Current psychiatric hospital inpatient Mayo Clinic time initiation treatment . Ability provide inform consent Male/Female Age 1865 yr . Major Depressive Disorder Bipolar Disorder I Bipolar Disorder II Patient Health Questionnaire9 ( PHQ 9 ) score ≥15 hospital assessment Treatment resistant depression ( TRD ) define least two previous antidepressant mood stabilize treatment depression adequate dose 8 week Patient report overall suicide risk score ≥3 Suicide Status Form ( SSF IIR ) score ≥1on Item 9 PHQ9 ( admission assessment ) Ability pas comprehension assessment test relate effect ketamine trial objective criteria Voluntary admission Diagnosis schizophrenia , schizoaffective disorder , active psychosis Index episode depression great 2 year Ongoing prescription ≥4 mg lorazepam equivalent total daily a.m. dose benzodiazepine time assessment Currently undergo electroconvulsive therapy , deep brain stimulation transcranial magnetic stimulation acute series maintenance Any active unstable medical condition judge principal investigator Previous use abuse methamphetamine , cocaine , stimulant ( prescribed illicit ) within past 12 month Any current abuse dependence alcohol drug ( except nicotine ) abuse dependence drug alcohol full remission ( &gt; 1 month , &lt; 12 month ) . Patients allow enroll drug alcohol abuse / dependence full ( complete , partial ) sustain ( &gt; 1 year ) remission . History traumatic brain injury Developmental delay intellectual disorder Encephalopathy ( clinical diagnosis within prior 12 month delirium ) Cognitive disorder ( mild major ) Previous participation earlier Ketamine trial Pregnancy Prisoners Involuntarily hospitalize</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Unipolar</keyword>
	<keyword>Bipolar</keyword>
	<keyword>Suicidal</keyword>
</DOC>